Gen-Probe (US) gets Transcription Mediated Amplification (TMA) patent
This article was originally published in Clinica
Executive Summary
Gen-Probe (US) has received a US patent for Transcription Mediated Amplification (TMA). A Mycobacterium tuberculosis test based on the technique received a conditional approval recommendation from the US FDA advisory panel on May 2nd (see this issue p 15). A urine and urogenital sample-based Chlamydia trachomatis kit will enter clinical trials in the near future and tests for HIV viral RNA, hepatitis B virus DNA and leukaemia are in development.